930: Clinical Outcome and Postoperative Chemotherapy Requirement in Patients with Clinical Stage IIA and IIB Non-Seminomatous Germ Cell Tumor (NSGCT) Following Primary Retroperitoneal Lymph Node Dissection: Impact of Preoperative Serum Tumor Markers (STM)

2004 ◽  
Vol 171 (4S) ◽  
pp. 247-247 ◽  
Author(s):  
Joel Sheinfeld ◽  
Andrew J. Stephenson ◽  
Robert J. Motzer ◽  
Dean F. Bajorin ◽  
George J. Bosl
Sign in / Sign up

Export Citation Format

Share Document